Literature DB >> 8659511

Huntington disease--another chapter rewritten.

M A Nance.   

Abstract

To those of us who began life when humans had 48 chromosomes and who began working in genetics when the (by then 46) chromosomes had no bands and chromosome 4 could not reliably be distinguished from chromosome 5, the mere ability to diagnose and correlate the clinical phenotypes of genetic disorders with their molecular genotypes is a source of continuing astonishment and pleasure. Indeed, molecular genetic analysis of neurogenetic disorders such as Huntington disease (HD) has provided a steady stream of challenges and surprises to all who believe the genetic principles that they were taught about these disorders. The paper by Rubinsztein et al. in this issue of the journal highlights yet another surprise, which was adumbrated even in the initial paper announcing the discovery of the HD gene: incomplete penetrance of HD gene mutations.

Entities:  

Mesh:

Year:  1996        PMID: 8659511      PMCID: PMC1915085     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  48 in total

1.  De novo expansion of a (CAG)n repeat in sporadic Huntington's disease.

Authors:  R H Myers; M E MacDonald; W J Koroshetz; M P Duyao; C M Ambrose; S A Taylor; G Barnes; J Srinidhi; C S Lin; W L Whaley
Journal:  Nat Genet       Date:  1993-10       Impact factor: 38.330

2.  Molecular analysis of new mutations for Huntington's disease: intermediate alleles and sex of origin effects.

Authors:  Y P Goldberg; B Kremer; S E Andrew; J Theilmann; R K Graham; F Squitieri; H Telenius; S Adam; A Sajoo; E Starr
Journal:  Nat Genet       Date:  1993-10       Impact factor: 38.330

3.  Analysis of the huntingtin gene reveals a trinucleotide-length polymorphism in the region of the gene that contains two CCG-rich stretches and a correlation between decreased age of onset of Huntington's disease and CAG repeat number.

Authors:  D C Rubinsztein; D E Barton; B C Davison; M A Ferguson-Smith
Journal:  Hum Mol Genet       Date:  1993-10       Impact factor: 6.150

4.  Borderline repeat expansion in Huntington's disease.

Authors:  K E de Rooij; P A de Koning Gans; M Losekoot; E Bakker; J T den Dunnen; M Vegter-van der Vlis; R A Roos; G J van Ommen
Journal:  Lancet       Date:  1993-12-11       Impact factor: 79.321

5.  Molecular analysis and clinical correlations of the Huntington's disease mutation.

Authors:  J C MacMillan; R G Snell; A Tyler; G D Houlihan; I Fenton; J P Cheadle; L P Lazarou; D J Shaw; P S Harper
Journal:  Lancet       Date:  1993-10-16       Impact factor: 79.321

6.  The relationship between trinucleotide (CAG) repeat length and clinical features of Huntington's disease.

Authors:  S E Andrew; Y P Goldberg; B Kremer; H Telenius; J Theilmann; S Adam; E Starr; F Squitieri; B Lin; M A Kalchman
Journal:  Nat Genet       Date:  1993-08       Impact factor: 38.330

7.  Correlation between the onset age of Huntington's disease and length of the trinucleotide repeat in IT-15.

Authors:  O C Stine; N Pleasant; M L Franz; M H Abbott; S E Folstein; C A Ross
Journal:  Hum Mol Genet       Date:  1993-10       Impact factor: 6.150

8.  Molecular analysis of juvenile Huntington disease: the major influence on (CAG)n repeat length is the sex of the affected parent.

Authors:  H Telenius; H P Kremer; J Theilmann; S E Andrew; E Almqvist; M Anvret; C Greenberg; J Greenberg; G Lucotte; F Squitieri
Journal:  Hum Mol Genet       Date:  1993-10       Impact factor: 6.150

9.  Mitotic stability and meiotic variability of the (CAG)n repeat in the Huntington disease gene.

Authors:  C Zühlke; O Riess; B Bockel; H Lange; U Thies
Journal:  Hum Mol Genet       Date:  1993-12       Impact factor: 6.150

10.  Trinucleotide repeat elongation in the Huntingtin gene in Huntington disease patients from 71 Danish families.

Authors:  A Nørremølle; O Riess; J T Epplen; K Fenger; L Hasholt; S A Sørensen
Journal:  Hum Mol Genet       Date:  1993-09       Impact factor: 6.150

View more
  4 in total

1.  Huntington's Disease.

Authors: 
Journal:  Curr Treat Options Neurol       Date:  2000-05       Impact factor: 3.598

2.  The likelihood of being affected with Huntington disease by a particular age, for a specific CAG size.

Authors:  R R Brinkman; M M Mezei; J Theilmann; E Almqvist; M R Hayden
Journal:  Am J Hum Genet       Date:  1997-05       Impact factor: 11.025

3.  ACMG/ASHG statement. Laboratory guidelines for Huntington disease genetic testing. The American College of Medical Genetics/American Society of Human Genetics Huntington Disease Genetic Testing Working Group.

Authors: 
Journal:  Am J Hum Genet       Date:  1998-05       Impact factor: 11.025

4.  Family history and DNA analysis in patients with suspected Huntington's disease.

Authors:  S Siesling; M Vegter-van de Vlis; M Losekoot; R D Belfroid; J A Maat-Kievit; H P Kremer; R A Roos
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-07       Impact factor: 10.154

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.